Innovent Biologics Inc. (6IB)
XSTU
Real-time Data
06:00 AM
Day's Range
10.6852 wk Range
7.82Overview - 6IB - Innovent Biologics Inc.
Key Statistics
Valuation
Enterprise Value
183.26M
Price / Sales (TTM)
‪1.12‬
EV / EBITDA
‪0.12‬
Profitability
Profit Margin
‪86.53%‬
Operating Margin
‪7.04%‬
Return on Assets
‪2.17%‬
Return on Equity
‪4.20%‬
Ownership
Shares Outstanding
1.73B
Price stats
50-Day Avg
‪9.16‬
200-Day Avg
‪9.17‬
Peers - 6IB - Innovent Biologics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- 6IBXSTUInnovent Biologics Inc.14.71BMarket Cap-2.15%52-week change—P/E (Trailing)‪86.53%‬Profit Margin
- 4KBXSTUKrystal Biotech Inc.8.74BMarket Cap+57.88%52-week change44.81P/E (Trailing)‪54.81%‬Profit Margin
- 2X10XSTUAbivax SA ADR8.72BMarket Cap+35.02%52-week change-20.39P/E (Trailing)‪0.00%‬Profit Margin
- 19XXSTUAxsome Therapeutics, Inc.7.98BMarket Cap+43.86%52-week change-48.38P/E (Trailing)‪92.56%‬Profit Margin
- 30JXSTUIdeaya Biosciences Inc.3.25BMarket Cap+33.59%52-week change-26.12P/E (Trailing)‪-74.75%‬Profit Margin
- AN6XSTUAnaptysBio Inc.1.48BMarket Cap+65.30%52-week change-107.13P/E (Trailing)—Profit Margin
- BSFAXSTUAni Pharmaceuticals Inc.1.45BMarket Cap-21.26%52-week change16.28P/E (Trailing)‪11.07%‬Profit Margin
Profile Summary - 6IB - Innovent Biologics Inc.
About
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmaceutical and biotechnology company based in China, Innovent is dedicated to advancing affordable and innovative…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
